Concepedia

Rakesh R. Ramjiawan

RR

10

Publications

1.5K

Citations

10

H-Index

2014

Active since

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Amsterdam UMC Location Vrije Universiteit Amsterdam

Institutul Clinic Fundeni

Tokyo Women's Medical University

Rakesh R. Ramjiawan is an author at Massachusetts General Hospital specializing in medicine, cell biology, and tumor microenvironment.

ORCID

Top concepts

Publications per year

2014–2023

10

Publications

10

CXCR4 inhibition in tumor microenvironment facilitates anti‐programmed death receptor‐1 immunotherapy in sorafenib‐treated hepatocellular carcinoma in mice

Yunching Chen, Rakesh R. Ramjiawan, Thomas Reiberger et al. · Hepatology · 2014 · 444 citations

Dual Programmed Death Receptor‐1 and Vascular Endothelial Growth Factor Receptor‐2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma

Kohei Shigeta, Meenal Datta, Tai Hato et al. · Hepatology · 2019 · 398 citations · Full text

Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma

Kohei Shigeta, Aya Matsui, Hiroto Kikuchi et al. · Journal for ImmunoTherapy of Cancer · 2020 · 143 citations · Full text

An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis

Thomas Reiberger, Yunching Chen, Rakesh R. Ramjiawan et al. · Nature Protocols · 2015 · 116 citations · Full text

, , +14

The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation

David P. Kodack, Vasileios Askoxylakis, Gino B. Ferraro et al. · Science Translational Medicine · 2017 · 108 citations · Full text

Rows per page

1–5 of 10